https://www.selleckchem.com/pr....oducts/i-bet151-gsk1
OBJECTIVE To find risk-factors for second-line dactinomycin failure in patients with low-risk gestational trophoblastic neoplasia (GTN). DESIGN Retrospective multicenter study. SETTING Tertiary reference centre. POPULATION Patients with low-risk GTN, treated with dactinomycin after methotrexate (MTX) failure. METHODS Retrospective analysis of 45 patients with low-risk GTN treated with dactinomycin after MTX failure, registered between 2006-2018. MAIN OUTCOME MEASURES Treatment outcome and risk-factors for second-line dactin
Like
Comment
Share
